Categories: Health Care Sector

First Trial of COVID Vaccine Approved for Children

The first trial of COVID vaccine approved for use in children between the ages of 5 and 18 will soon begin, the Director of Research at the Finlay Vaccine Institute (IFV), Dagmar García Rivero announced. She said the documentation is being prepared for the regulatory authorities.

Ms. Garcia told a news broadcast of the Cuban program, Noticiero Estelar, that “advancing to a clinical trial in children takes higher regulatory rigor, and therefore we normally need to advance in adult populations before evaluating vaccine candidates in children.”

“We remain determined to move in the near term to pediatric clinical trials. Currently this clinical trial is under review. We would be talking about evaluating the best formulation of the Soberana 01 and Soberana 02 vaccine candidates in the pediatric population. We have decided to move into the age range of 5 to 18 years of age, starting first in the 12 to 18 year old population. Once safety is established in this group, we will move down to the 5 to 12 age range.”

According to scientists of the Finlay Institute, Phase I of clinical trials could begin in April, which could guarantee the mass vaccination of this age group by the summer if no difficulties arise.

Advertisement. Scroll to continue reading.

Thimerosal and vaccines

The specialist also spoke about thimerosal in Cuban vaccines.

Ms. García said that the first batches of the vaccines used in the studies contained the thimerosal (a preservative) which limited the volunteers who participated in the study if they were allergic to it.

“It is important to point out that at the moment the single-dose batches that are being produced at the National Center of Biopreparations (BIOCEN) do not contain thimerosal, and this will undoubtedly be the alternative for that segment of the population that reports a history of allergy to this preservative.”

The website of the Center of Disease Control states that Thimerosal is a mercury-based preservative that has been used for decades in the U.S. for vials containing more than one dose of medicine and vaccines and that there is no evidence of harm caused by the low doses of thimerosal in vaccines.

Advertisement. Scroll to continue reading.

Dagmar also confirmed that there is no campaign to vaccinate tourists, and that only those participating in the COVID vaccine trials have been vaccinated.

She also confirmed that persons over 80 years of age were never vaccinated.

Cuba has not received imported vaccines from any other country supplier.

Advertisement. Scroll to continue reading.
Share
Published by
David Urra

Recent Posts

Cuba Joins the BRICS New Development Bank

In a move with both economic and geopolitical significance, Cuba has officially joined the New…

1 week ago

Cuba’s International Tourist Arrivals—June 2025

Cuba’s tourism sector, long a vital part of the island’s economy, is experiencing mixed fortunes…

2 weeks ago

Cuba Amplifies Voice of the Global South at BRICS 2025 in Brazil

Cuba took center stage at the 17th BRICS 2025 in Rio de Janeiro this weekend,…

1 month ago

FIHAV 2025 Set for this November

Cuba has confirmed the 41st edition of the Havana International Fair (FIHAV 2025) will take…

1 month ago

WestJet CEO Meets with Cuban President Amid Hopes for Expansion of Passenger Flights to Havana

WestJet CEO Alexis von Hoensbroech met Wednesday with Cuban President Miguel Díaz-Canel in Havana, a high-level meeting…

2 months ago

Cuba Expands Solar Parks as Energy Deficits Persist

Cuba is ramping up efforts to address energy shortages through the expansion of photovoltaic solar…

2 months ago